Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of Survivin Gene in Cancer Cells.
From: New England Biolabs, Ipswich, Massachusetts 01938-2723, USA.
The Journal of biological chemistry
- Publish Date: Jan 2007
- ISSN: 0021-9258
- Volume: 282
- Issue: 4
- Pages: 2615-25
- Medium: Print
- Language: English
- Citation (JAMA): Estève Pierre-Olivier, Chin Hang Gyeong, Pradhan Sriharsa, et al. Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of Survivin Gene in Cancer Cells.. J. Biol. Chem. Jan 2007;282:2615-25
Abstract
Human maintenance DNA cytosine methyltransferase (DNMT1) regulates gene expression in a methylation-dependent and -independent manner. Anti-apoptotic survivin gene down-regulation is mediated by p53 recruitment of DNMT1 to its promoter. Survivin inhibits programmed cell death, regulates cell division, and is expressed in cancer cells. The survivin gene promoter is CG-rich containing several Sp1 canonical, Sp1-like, cell cycle-dependent element/cell cycle gene homology region, and p53-binding sites. Here we demonstrate that Sp1 transcription factor(s) play a role in transcriptional activation of the survivin promoter in Drosophila and human cells. Sp1 inhibition in vivo by mithramycin A leads to down-regulation of a luciferase reporter driven by the human survivin promoter in transfected cells. Mithramycin A or Sp1-specific short interfering RNA down-regulated the endogenous survivin gene expression, confirming Sp1 as the primary determinant for transcriptional activation. Furthermore, immobilized DNMT1 ligand bound to seven consensus amino acids corresponding to the N-terminal region of the Sp class of transcription factors in a phage display analysis. In the co-immunoprecipitation assay, the endogenous Sp1 or Sp3 pulled down DNMT1 and methyltransferase activity. Similarly, a glutathione S-transferase pulldown assay between DNMT1 and Sp1 demonstrates a direct interaction between the two proteins. Fluorescent fusions of DNMT1 and Sp1 co-localized in the mammalian nucleus, thus supporting binary complex formation between both the proteins. The kinetics of survivin promoter occupancy via chromatin immunoprecipitation following doxorubicin treatment show the presence of Sp1 and gradual accumulation of transcriptional repressors p53, DNMT1, histone methyltransferase G9a, and HDAC1 onto the promoter along with histone H3K9me2. These data suggest that the Sp1 transcription factor acts as a platform for recruitment of transcriptional repressors.
Mesh Headings (Keywords): Animals, Antibiotics, Antineoplastic, Cell Line, Tumor, DNA (Cytosine-5-)-Methyltransferase, DNA Damage, DNA Methylation, Doxorubicin, Drosophila melanogaster, Gene Expression Regulation, Neoplastic, Genes, p53, Histone Deacetylases, Histones, Humans, Microtubule-Associated Proteins, Neoplasm Proteins, Neoplasms, Promoter Regions (Genetics), Sp1 Transcription Factor, Trans-Activation (Genetics)
Check for Full Text / PubMed Unique Identifier (PMID): 17124180
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.